Methods: This study was a
cross-sectional study on the use of penicillins in outpatients. Approved and
unapproved indications were determined from records of the Food and Drug
Administration (FDA) of the United States and the National Institute of Food
and Drug Surveillance (INVIMA) of Colombia. Descriptive and multivariate analyses
were performed.
Results: A total of 137,070
patients were identified; the average age was 35.8 ± 23.5 years, and 56.2% were
women. Amoxicillin (73.4%), dicloxacillin (11.7%) and sultamicillin (6.0%) were
the most commonly prescribed penicillins, mainly for upper respiratory tract
infections (43.0%). In 68.9% of cases, penicillins were used for approved
indications, especially to treat Helicobacter
pylori (17.3%). In 31.1% of cases, penicillin prescriptions were used for
unapproved indications (e.g., acute rhinopharyngitis [8.1%]). Patients under 18
years of age (OR: 1.87; 95% CI: 1.78-1.96), those from municipalities (OR:
1.51; 95% CI: 1.44-1.57), those with previous antibiotic use (OR: 2.49; 95% CI:
2.26-2.74), those with skin and soft tissue infections (OR: 2.82; 95% CI:
2.57-3.09), those with lower respiratory tract infections (OR: 2.02; 95% CI:
1.89-2.16), those managed with general medicine (OR: 1.37; 95% CI: 1.25-1.51),
and those treated with dicloxacillin (OR: 2, 84; 95% CI: 2.07-3.89) were more
likely to be prescribed penicillins for unapproved indications.